DeutschNewstral
Article
bizjournals.com on 2015-10-30 00:33
This Seattle venture firm just raised $262M to focus on biotech
Related news
- Biotech led venture-backed IPOs nationally in 2014 including Juno Therapeutics, 3 other Seattle biotechsbizjournals.com
Seattle biotech firm Silverback Therapeutics aims for $100M IPOSeattle Times- This Seattle biotech just raised $3.5M to pursue Alzheimer's, other brain disease drugsbizjournals.com
- Do California's incentives lure biotech companies that could have been in Seattle?bizjournals.com
- A Seattle venture firm has a new $300M fund. Here's why that's good for Portlandbizjournals.com
Seattle biotech PhaseRx files to go publicseattletimes.com
Seattle biotech firm to train WSU medical students in ‘bold, audacious and visionary’ approach - Tue, 11 Apr 2017 PSTThe Spokesman-Review
Barack Obama visits venture capital firm on California triplasvegassun.com
Top Venture Capital Firm Tight Lipped About Barack Obama Visitbreitbart.com
Seattle brothers expand billion-dollar biotech company’s focus to include COVIDthenewstribune.com- Gates Foundation leads $14M funding round for Seattle biotechbizjournals.com
- Here's why one biotech, courted by San Diego, decided to stay in Seattlebizjournals.com
- Seattle biotech Kineta lands $4M contract to develop immunotherapy for infectious diseasebizjournals.com
- Seattle biotech faces tough decision about its next CEO in midst of proxy battlebizjournals.com
- Boulder biotech acquires Seattle companybizjournals.com
- Seattle biotech expands portfolio with Boston acquisitionbizjournals.com
- Seattle biotech Adaptive lives up to its name, pivots toward drug developmentbizjournals.com
ABQ biotech firm moving to San Diegoabqjournal.com
Vancouver biotech firm Absci files for IPOoregonlive.com